No trading action warranted. This is a routine administrative filing reflecting standard employee share scheme issuances. Monitor for any future material filings such as earnings or pipeline updates.
Price Chart
Executive Summary
AstraZeneca filed a routine 6-K notification of admission of 10,072 ordinary shares to trading on the London Stock Exchange, issued under the company's employee share schemes between 1 August 2026 and 31 August 2026. The total shares in issue post-admission is 1,551,043,461. This is a standard administrative filing with no material financial or operational impact, representing dilution of less than 0.001% of outstanding shares.
Key Facts
- 10,072 ordinary shares of $0.25 each were admitted to trading on the London Stock Exchange.
- Shares were issued under employee share schemes between 1 August 2026 and 31 August 2026.
- Total shares in issue after admission: 1,551,043,461.
- The new shares are fully fungible with existing ordinary shares.
Financial Impact
Dilution of approximately 0.00065% of outstanding shares, negligible economic impact.
Risk Factors
- None identified from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (AZN) — Batch item 1 | 0001654954-26-008042 |
| Document: 0001654954-26-008042-index-headers.html | 0001654954-26-008042 |
| Document: 0001654954-26-008042-index.html | 0001654954-26-008042 |
| Document: 0001654954-26-008042.txt | 0001654954-26-008042 |
| 6-K Filing (AZN) — Batch item 5 | 0001654954-26-008042 |
| Document: 0001654954-26-008042-index-headers.html | 0001654954-26-008042 |
| Document: 0001654954-26-008042-index.html | 0001654954-26-008042 |
| Document: 0001654954-26-008042.txt | 0001654954-26-008042 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | 6-K | $161.85 $168.37 | ▲ +4.03% | ▲ +1.90% | $157.02 (−2.98%) |
Sep 14, 2026 18d ago | 6-K | $163.78 $168.10 | ▼ −2.64% | ▼ −2.53% | $157.02 (+4.13%) |
Sep 8, 2026 24d ago | 6-K | $160.04 $161.85 | ▲ +1.13% | ▲ +2.25% | $157.02 (−1.89%) |
Sep 1, 2026 4w ago | 6-K | $162.22 $156.94 | ▼ −3.25% | ▼ −3.33% | $157.02 (−3.20%) |
Sep 1, 2026 4w ago | 6-K | $162.22 $156.94 | ▼ −3.25% | ▼ −3.33% | $157.02 (−3.20%) |
Sep 1, 2026 4w ago | 6-K | $162.47 $156.94 | ▼ −3.40% | ▼ −3.49% | $157.02 (−3.35%) |
Sep 1, 2026 4w ago | 6-K | $162.22 $156.94 | ▼ −3.25% | ▼ −3.33% | $157.02 (−3.20%) |
Sep 1, 2026 4w ago | 6-K | $162.22 $156.94 | ▼ −3.25% | ▼ −3.33% | $157.02 (−3.20%) |
Sep 1, 2026 4w ago | 6-K | $162.47 $156.94 | ▼ −3.40% | ▼ −3.49% | $157.02 (−3.35%) |
Aug 31, 2026 4w ago | Court Ruling | $162.13 $159.95 | ▲ +1.34% | ▲ +1.20% | $157.02 (+3.15%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access